Divyashakti Q4 FY26 Results: Loss Rs 2.8 Cr
- May 25, 2026
- Posted by: Kashish Aggarwal
- Category: News
Divyashakti Q4 FY26 results were declared on May 24, 2026. The company reported net loss of Rs 2.8 crore for the quarter ended March 31, 2026, down 660.0% YoY compared to Rs 0.5 crore in Q4 FY25. Revenue from operations was Rs 0.5 crore, down 95.8% YoY. Results are on a Standalone basis. Divyashakti is a Pharmaceuticals company listed on Indian stock exchanges.
Click Here – Get Free Investment Predictions
Divyashakti Q4 FY26 Financial Highlights
| Metric | Q4 FY26 (Rs Cr) | Q4 FY25 (Rs Cr) | YoY Change |
|---|---|---|---|
| Revenue | Rs 0.5 crore | Rs 12 crore | -95.8% |
| Net Loss | 2.8 | 0.5 | -660.0% |
| Basis | Standalone | ||
Note: Q4 FY26 revenue collapse and margin erosion signal deep operational distress. Net loss Rs 2.8 crore. Verify from BSE/NSE audited filings before investment decisions.
Divyashakti Q4 FY26 Performance Analysis
The Divyashakti Q4 FY26 results reflect the company’s financial performance during the January to March 2026 quarter. The quarter reflects near-term profitability challenges. Divyashakti operates in the Pharmaceuticals sector, supported by India’s GDP growth above 6.5% in FY26.
Revenue of Rs 0.5 crore was down 95.8% YoY. Revenue moderation reflects near-term demand headwinds.
Screen the best stocks on the Univest Screener.
Key Factors Driving Divyashakti Q4 FY26 Results
Revenue and Business Performance
Revenue of Rs 0.5 crore in Divyashakti Q4 FY26 was down 95.8% YoY. Revenue pressure reflects near-term demand headwinds in the Pharmaceuticals market. The January to March quarter is the fiscal year-end period characterised by strong order execution cycles.
Profitability and Margin Trends
The the business net loss of Rs 2.8 crore down 660.0% YoY. The net loss reflects ongoing operational challenges. Cost discipline and revenue recovery remain FY27 priorities.
India Macro Environment
India’s macro environment in Q4 FY26 was supportive with GDP growth above 6.5%, government capex of Rs 11.21 lakh crore budgeted for FY27, and resilient domestic consumption. The Pharmaceuticals sector benefited from these structural tailwinds during the January to March 2026 quarter.
FY27 Outlook
Following the firm results, management guidance on FY27 revenue growth, margin improvement, and capital allocation will be key investor watchpoints. Returning to profitability through operational improvements remains the key FY27 objective.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
Frequently Asked Questions on the company
What is Divyashakti Q4 FY26 net loss?
Ans. Divyashakti Q4 FY26 net loss of Rs 2.8 crore, down 660.0% YoY from Rs 0.5 crore in Q4 FY25. Results declared May 24, 2026, on a Standalone basis.
What is Divyashakti Q4 FY26 revenue?
Ans. Divyashakti Q4 FY26 revenue was Rs 0.5 crore, down 95.8% YoY. Verify from BSE/NSE filings.
When were Divyashakti Q4 FY26 results declared?
Ans. Divyashakti Q4 FY26 results were declared on May 24, 2026, at the board of directors meeting approving audited Q4 and full-year FY26 financial statements.
Is Divyashakti a good investment after Q4 FY26?
Ans. Investment decisions require individual assessment of fundamentals, valuation, and risk. This article is educational only. Consult a SEBI-registered financial advisor before investing.
Investments in securities are subject to market risk. This content is for educational purposes only. Verify all figures from BSE/NSE filings. Consult a SEBI-registered financial advisor.
